Ameriprise’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$268K Hold
42,682
– – ﹤0.01% 3950
2026
Q2
$303K Buy
42,682
+413
+1% +$2.96K ﹤0.01% 3837
2026
Q1
$283K Sell
42,269
-573
-1% -$3.29K ﹤0.01% 3773
2025
Q4
$233K Sell
42,842
-77,898
-65% -$463K ﹤0.01% 3882
2025
Q3
$746K Buy
120,740
+36,182
+43% +$237K ﹤0.01% 3481
2025
Q2
$529K Buy
84,558
+20,065
+31% +$117K ﹤0.01% 3510
2025
Q1
$378K Sell
64,493
-21,093
-25% -$160K ﹤0.01% 3596
2024
Q4
$704K Sell
85,586
-2,006
-2% -$18.9K ﹤0.01% 3399
2024
Q3
$780K Buy
+87,592
New +$751K ﹤0.01% 3316

Other funds holding AURA

Ameriprise's AURA Position: Q3 2026 in Review

Ameriprise held its Aura Biosciences (AURA) position steady in Q3 2026 at 42,682 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #3950.

Ameriprise first reported a position in AURA in Q3 2024 and has held it in 9 quarters since. The position peaked at $780K in Q3 2024. 152 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Ameriprise held 42,682 shares of Aura Biosciences worth $268K as of Q3 2026.
  • Ameriprise left its Aura Biosciences share count unchanged in Q3 2026.
  • Aura Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #3950 holding.
  • Ameriprise first reported a position in Aura Biosciences in Q3 2024 and has held it in 9 quarters since.
  • Ameriprise's Aura Biosciences position peaked at $780K in Q3 2024.
  • 152 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.